Timothy Sullivan
2020
In 2020, Timothy Sullivan earned a total compensation of $3.5M as Chief Financial Officer at Apellis Pharmaceuticals, a 103% increase compared to previous year.
Compensation breakdown
| Bonus | $244,688 |
|---|---|
| Option Awards | $2,279,063 |
| Salary | $430,269 |
| Stock Awards | $518,129 |
| Other | $13,000 |
| Total | $3,485,149 |
Sullivan received $2.3M in option awards, accounting for 65% of the total pay in 2020.
Sullivan also received $244.7K in bonus, $430.3K in salary, $518.1K in stock awards and $13K in other compensation.
Rankings
In 2020, Timothy Sullivan's compensation ranked 3,332nd out of 13,090 executives tracked by ExecPay. In other words, Sullivan earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,332 out of 13,090 | 75th |
Division Manufacturing | 1,293 out of 5,624 | 77th |
Major group Chemicals And Allied Products | 488 out of 2,257 | 78th |
Industry group Drugs | 423 out of 1,957 | 78th |
Industry Pharmaceutical Preparations | 317 out of 1,462 | 78th |
Source: SEC filing on April 22, 2021.
Sullivan's colleagues
We found four more compensation records of executives who worked with Timothy Sullivan at Apellis Pharmaceuticals in 2020.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019